Skip to main content
logo
Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
1.090
+0.010 (0.93%)
Sep 4, 2026, 4:00 PM EDT - Market closed

Cardiff Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
851892896663252
Market Cap Growth
-34.97%-34.44%336.64%5.71%-75.20%-60.31%
Enterprise Value
51130233-13-49121
Last Close Price
1.092.814.341.481.406.01

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
166.92319.20422.72135.50162.04702.51
PB Ratio
2.814.173.480.950.591.80
P/TBV Ratio
3.204.173.480.950.591.80

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
99.87218.72340.75--338.28

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.020.020.030.030.02
Net Debt / Equity Ratio
-1.28-1.27-1.09-1.04-0.96-0.98
Net Debt / EBITDA Ratio
0.811.181.871.612.594.85
Net Debt / FCF Ratio
0.831.512.392.312.955.92
Asset Turnover
0.010.010.010.010.000.00
Quick Ratio
3.223.596.927.2513.5821.55
Current Ratio
3.303.677.087.4214.2522.28
Return on Equity (ROE)
-94.08%-71.45%-59.51%-47.07%-31.37%-21.07%
Return on Assets (ROA)
-46.73%-38.47%-34.01%-28.69%-18.77%-12.69%
Return on Capital Employed (ROCE)
-159.30%-107.60%-58.10%-63.80%-36.80%-20.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-47.26%-24.22%-15.74%-62.67%-61.88%-11.22%
FCF Yield
-48.25%-20.06%-13.08%-47.59%-55.68%-9.22%
Buyback Yield / Dilution
-15.77%-40.27%-6.65%-2.47%-11.71%-86.97%
SEC Filings: 10-K · 10-Q